HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer.

Abstract
A 53-year-old man was diagnosed with polymyositis (PM) in 1997 and treated with prednisolone. The subjective symptoms of pneumonitis were poor. However, the KL-6 values were elevated to 2230 IU/l in March 2001. Abdominal computer tomography findings revealed a pancreatic-tail tumor and multiple liver nodules, diagnosed as primary pancreatic adenocarcinoma with multiple liver metastasis. The stage of the pancreatic cancer was IV, and curative surgery of the tumor was not indicated. Chemotherapy and radiotherapy were administered for the liver metastasis. However, these therapies were ineffective against the tumors. The patient died on 12 September 2001. If a high level of KL-6 is found without the increasing activity of lung disease containing interstitial pneumonia in PM patients, examination for the internal malignancies including pancreatic cancer should be performed, although cases of PM with a significantly high level of KL-6 associated with pancreatic cancer are rare.
AuthorsYohei Kida, Etsuko Maeshima, Kanako Furukawa, Tomohiro Ichikawa, Mikako Goda, Masakazu Ichinose
JournalModern rheumatology (Mod Rheumatol) Vol. 17 Issue 3 Pg. 262-4 ( 2007) ISSN: 1439-7595 [Print] England
PMID17564787 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, Neoplasm
  • MUC1 protein, human
  • Mucin-1
  • Mucins
Topics
  • Adenocarcinoma (complications, diagnosis, immunology, secondary)
  • Antigens, Neoplasm (metabolism)
  • Humans
  • Liver Neoplasms (secondary)
  • Male
  • Middle Aged
  • Mucin-1
  • Mucins (metabolism)
  • Pancreatic Neoplasms (complications, diagnosis, immunology, pathology)
  • Polymyositis (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: